TY - JOUR
T1 - Imipramine for the treatment of fibrositis
T2 - A therapeutic trial
AU - Wysenbeek, A. J.
AU - Mor, F.
AU - Lurie, Y.
AU - Weinberger, A.
PY - 1985
Y1 - 1985
N2 - Twenty fibrositic patients were treated with imipramine 50-75 mg/day. Only two patients responded favourably. Nineteen patients stopped therapy during the initial three-month period; 14 of them due to lack of response, while to of these concomitantly disclosed side effects. The additional five patients stopped therapy mainly due to side effects while only one of them improved with therapy. One patient, only, improved and adhered to therapy for more than three months.
AB - Twenty fibrositic patients were treated with imipramine 50-75 mg/day. Only two patients responded favourably. Nineteen patients stopped therapy during the initial three-month period; 14 of them due to lack of response, while to of these concomitantly disclosed side effects. The additional five patients stopped therapy mainly due to side effects while only one of them improved with therapy. One patient, only, improved and adhered to therapy for more than three months.
UR - http://www.scopus.com/inward/record.url?scp=0022395884&partnerID=8YFLogxK
U2 - 10.1136/ard.44.11.752
DO - 10.1136/ard.44.11.752
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
AN - SCOPUS:0022395884
SN - 0003-4967
VL - 44
SP - 752
EP - 753
JO - Annals of the Rheumatic Diseases
JF - Annals of the Rheumatic Diseases
IS - 11
ER -